inqaba biotec acquires the first PacBio Sequel II System in Africa

MENLO PARK, Calif. and PRETORIA, South Africa, April 20, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, and inqaba biotec, the leading commercial DNA sequencing service provider in sub-Saharan Africa, today announced the addition of a PacBio Sequel II System to inqaba... Read more

Bio-Techne Introduces Replex Capabilities for Simple Western Assays on Jess

APRIL 16, 2020 MINNEAPOLIS, April 16, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced the upcoming release of RePlex™ for use on the Jess instrument, a member of the Simple Western™ instrument family. RePlex adds to Jess’s already advanced, fully automated, capillary electrophoresis-based Western blotting capabilities by allowing users to analyze the same sample twice... Read more

BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use

New Test Uses BD MAX™ System to Augment Supply from Existing Collaborations; Test Results in Under Three HoursApr 13, 2020 FRANKLIN LAKES, N.J., April 13, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)... Read more

Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call

Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call WASHINGTON, April 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue growth of approximately 4.5%.... Read more

Thermo Fisher Scientific Provides COVID-19 Business Update and Will Hold First Quarter Earnings Conference Call on Wednesday, April 22, 2020

Thermo Fisher Scientific Provides COVID-19 Business Update and Will Hold First Quarter Earnings Conference Call on Wednesday, April 22, 2020 WALTHAM, Mass., April 6, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, due to the evolving COVID-19 pandemic and related customer impact, it is withdrawing 2020... Read more

10x Genomics Appoints Kim Popovits to Board of Directors

April 2, 2020 at 9:00 AM EDTPDF VersionFormer Genomic Health CEO brings decades of healthcare experience to Board PLEASANTON, Calif., April 02, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced the appointment of Kim Popovits, former Chairman of the Board, President and Chief Executive Officer of Genomic Health, Inc., to the company’s Board of Directors.  She brings... Read more

Promega GoTaq® Probe 1-Step RT-qPCR System Approved for Use in CDC’s COVID-19 Emergency Use Authorization Diagnostic Panel

Promega amplification reagent added to EUA list for laboratories that follow CDC’s testing protocols Madison, WI USA. (April 1, 2020) Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus... Read more

SCIEX Debuts Breakthrough Method for Gene Therapies

Robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis April 01, 2020 Framingham, MA — SCIEX, a global leader in life science analytical technologies, launched an exciting new method for streamlining and improving the production of gene therapies. This innovative capillary electrophoretic method addresses a key customer challenge by analyzing AAVs... Read more

UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network

Mon 23rd March 2020 The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The network aims to sequence the virus from every patient sample that has tested positive. The resulting data will help deliver insights into how the virus is transmitted and... Read more